Stereotactic body radiation therapy and oligometastases

被引：4

作者：

Bourgier, C. ^{[1
,2
,3
]}

Azria, D. ^{[1
,2
,3
]}

Fenoglietto, P. ^{[1
]}

Riou, O. ^{[1
,2
]}

Almaghrabi, M. -Y. ^{[4
,5
]}

Supiot, S. ^{[4
,5
]}

Mornex, F. ^{[6
]}

Giraud, P. ^{[7
,8
]}

机构：

[1] Inst Reg Canc Montpellier, Serv Radiotherapie, F-34298 Montpellier 05, France

[2] INSERM, U896, F-34298 Montpellier 05, France

[3] Univ Montpellier I, U896, F-34298 Montpellier 05, France

[4] Inst Cancerol Ouest Rene Gauducheau, F-44805 St Herblain, France

[5] Ctr Rech Cancerol Nantes Angers, Inserm UMR, F-44007 Nantes 1, France

[6] Ctr Hosp Lyon Sud, Dept Radiotherapie Oncol, F-69310 Lyon, France

[7] Hop Europeen Georges Pompidou, Serv Oncol Radiotherapie, F-75015 Paris, France

[8] Univ Paris 05, F-75006 Paris, France

来源：

CANCER RADIOTHERAPIE | 2014年 / 18卷 / 04期

关键词：

Extracranial stereotactic irradiation; Oligometastases; RENAL-CELL CARCINOMA; METASTATIC BREAST-CANCER; EXTRACRANIAL OLIGOMETASTASES; SYNCHRONOUS METASTASES; COLORECTAL-CANCER; LIVER METASTASES; RADIOTHERAPY; DISEASE; SURVIVAL; TRIAL;

D O I：

10.1016/j.canrad.2014.02.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In stage IV cancers, locoregional management of primitive tumours as surgery and/or radiotherapy improved both progression-free survival and overall survival. Among metastatic cancer patients, some of them are considered as oligometastatic stage as they present few metastatic sites associated with low tumor aggressiveness. For those patients, metastatic local control, and therefore prolonged time to progression should be reached through local treatments as surgery and/or radiofrequency ablation and/or stereotactic radiotherapy. Here we propose a review of oligometastatic stage and results from extracranial stereotactic radiotherapy in terms of efficacy and tolerance. (C) 2014 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

引用

页码：337 / 341

页数：5

共 47 条

[1]

[Anonymous], 1997, J THORAC CARDIOVASC

[2]

[Anonymous], ARCH SURG

[3] CLINICAL OUTCOME OF HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY FOR ABDOMINAL LYMPH NODE METASTASES [J].

Bignardi, Mario ;

Navarria, Piera ;

Mancosu, Pietro ;

Cozzi, Luca ;

Fogliata, Antonella ;

Tozzi, Angelo ;

Castiglioni, Simona ;

Carnaghi, Carlo ;

Tronconi, Maria Chiara ;

Santoro, Armando ;

Scorsetti, Marta .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (03) :831-838

[4] Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease [J].

Bourgier, Celine ;

Khodari, Wassim ;

Vataire, Anne-Lise ;

Pessoa, Eduardo Lima ;

Dunant, Ariane ;

Delaloge, Suzette ;

Uzan, Catherine ;

Balleyguier, Corinne ;

Mathieu, Marie-Christine ;

Marsiglia, Hugo ;

Arriagada, Rodrigo .

RADIOTHERAPY AND ONCOLOGY, 2010, 96 (02) :199-203

[5]

Clinicaltrials.gov, REG RES DAT PUBL PRI

[6] Stereotactic body radiation therapy (SBRT) in the treatment of liver metastases: State of the art [J].

De Bari, B. ;

Guillet, M. ;

Mornex, F. .

CANCER RADIOTHERAPIE, 2011, 15 (01) :72-76

[7] Stereotactic body radiation therapy for liver primary and metastases: The Lille experience [J].

Dewas, S. ;

Mirabel, X. ;

Kramar, A. ;

Jarraya, H. ;

Lacornerie, T. ;

Dewas-Vautravers, C. ;

Fumagalli, I. ;

Lartigau, E. .

CANCER RADIOTHERAPIE, 2012, 16 (01) :58-69

[8] The 2003 revised TNM staging system for breast cancer: Results of stage re-classification on survival and future comparisons among stage groups [J].

Escobar, Pedro F. ;

Patrick, Rebecca J. ;

Rybicki, Lisa A. ;

Weng, David E. ;

Crowe, Joseph P. .

ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (01) :143-147

[9] Contemporary surgical treatment of advanced-stage melanoma [J].

Essner, R ;

Lee, JH ;

Wanek, LA ;

Itakura, H ;

Morton, DL .

ARCHIVES OF SURGERY, 2004, 139 (09) :961-966

[10]

FISHER B, 1980, CANCER-AM CANCER SOC, V46, P1009, DOI 10.1002/1097-0142(19800815)46:4+<1009::AID-CNCR2820461326>3.0.CO

← 1 2 3 4 5 →